JPRN-UMIN000005260
Completed
未知
Efficacy of myocardial protection by nicorandil during open-heart surgery under cardiopulmonary bypass - Myocardial protection by nicorandil
Kansai Medical University, Dept. Anesthesiology0 sites60 target enrollmentApril 1, 2011
Conditionsvalvular heart disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- valvular heart disease
- Sponsor
- Kansai Medical University, Dept. Anesthesiology
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •emergency surgery
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Evaluation of the effects of the cardioprotective diet on prevention of the incidence of cardiotoxicitycardiotoxicity in patients with breast cancer receiving Anthracycline.Malignant NeoplasmsC00-C97IRCT20131218015860N7School of Traditional Medicine, Traditional Medicine and Materia Medica Research Center,Shahid Behes60
Completed
Phase 3
Myocardial protection in cardiac surgeryCardiopulmonary bypass.Nonrheumatic mitral valve disorder, unspecifiedI34.9IRCT20191024045227N1Iran University of Medical Sciences74
Recruiting
Not Applicable
Evaluation of Cardioprotective Nutrition in people with Metabolic Syndrome and High Blood Pressure: a randomized clinical trialRBR-9v9r6vjniversidade do Estado da Bahia - UNEB
Completed
Not Applicable
Comparative analysis of two solutions for miocardial protection in the correction of congenital cardiopathies.Children with acyanogenic congenital heart defects operated for total correctionTraced problems - Myocardial damageSpecific descriptors - Interventricular communication, Atrioventricular communication, Right ventricle with double outlet, Tetralogy of Fallot, Myocardial protection.Q21.0Q21.2Q20.1Q21.3C14.280H02.403.670C14.280.647C14.280.671RBR-9wqbx9Hospital do Coração de Messejana Dr. Carlos Alberto Studart Gomes
Not yet recruiting
Not Applicable
A clinical trial to study the cardioprotective effect of remote ischemic preconditioning in acute coronary syndrome patientsHealth Condition 1: I228- Subsequent ST elevation (STEMI) myocardial infarction of other sitesCTRI/2023/10/058663Department of Health Research